Is it Possible to Predict Massive Bleeding in Nulliparous Women with Placenta Previa?

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine

Background:

• Placenta previa is a significant cause of antepartum hemorrhage.
• Massive bleeding in nulliparous women with placenta previa poses risks to both mother and fetus.
• Identifying predictive factors for massive bleeding is crucial for timely intervention.

Purpose of the Study:

• To evaluate potential risk factors for predicting massive bleeding in nulliparous women diagnosed with placenta previa.
• To determine if clinical, delivery, or placental characteristics could serve as predictors for severe hemorrhage.

Main Methods:

• A case-control study design was employed, classifying participants into massive bleeding (≥ 1,000 mL blood loss) and non-massive bleeding (< 1,000 mL blood loss) groups.
• Data collected included maternal and fetal factors, placental location, and delivery characteristics.
• Statistical analysis was performed to compare characteristics between the two bleeding groups.

Main Results:

• Of 69 participants, 28 (40.6%) experienced massive bleeding, and 41 (59.4%) had non-massive bleeding.
• Statistically significant differences were observed in calculated blood loss and the requirement for red blood cell transfusions between the groups (p < 0.005 and p = 0.002, respectively).
• No significant differences were found in maternal/fetal factors, placental location, or delivery characteristics between the massive and non-massive bleeding groups.

Conclusions:

• This study could not identify specific clinical, delivery, or placental features that predict massive hemorrhage in nulliparous women with placenta previa.
• The findings suggest that current clinical assessments may be insufficient for predicting severe bleeding events in this population.
• Further investigation is warranted to uncover reliable predictors for massive bleeding in placenta previa cases.